Record Quarterly and Strong Annual Revenues
Reported record fourth-quarter revenues of $488 million, up 11% year-over-year, and full year adjusted revenues of $1.54 billion, up 28% versus 2024.
M&A and Capital Markets Driving Growth
M&A revenues grew 35% year-over-year and capital markets delivered a record-setting year with double-digit increases in both average fees and number of completed transactions, driving the firm's revenue mix (~2/3 M&A, ~1/3 non-M&A).
Margin and EPS Expansion
Adjusted pretax margin improved to 21.5% for the full year (510 basis points improvement from 16.4% in 2024) and Q4 adjusted pretax margin was 28.6%. Adjusted EPS rose to $2.99 for 2025, a 64% increase from $1.82 in 2024.
Operating Leverage via Compensation Improvements
Full-year adjusted compensation ratio improved to 65.8% (down from 69% in 2024, a 320 basis point improvement). Q4 adjusted compensation ratio was 61.1%.
Expense Efficiency Gains
Adjusted non-compensation expense ratio decreased to 14.6% for the full year (from 15.9% in prior year) and was 12.4% in Q4, despite investments in technology and deal activity.
Private Capital Advisory (PCA) Momentum
Substantial 2025 investments in PCA produced meaningful early traction: team additions (including MD hires focused on private credit secondaries), a growing GP-led secondaries pipeline, and expectation PCA will become a core fourth pillar of the firm.
Talent Expansion and Depth
Added 21 Managing Directors in 2025 (including 9 laterals) and promoted 13 professionals to MD in early 2026, bringing total MD count to 178, positioning the firm with deeper sector expertise.
Strong Capital Position and Shareholder Returns
Ended with $849 million cash and no debt; returned ~$284 million to shareholders in 2025 (dividends, net settlement of shares, repurchases). Repurchased ~716,000 shares in Q4 at an average $62.96, total repurchases ~950,000 for the year, and Board authorized a new $300 million buyback program with no expiration. Quarterly dividend declared at $0.65 per share.